Recent Updates
Recently added Catalysts
SMTI Neutral Sentiment

In Vitro Evaluation of Microbicidal Efficacy of BIASURGE® Advanced Surgical Solution

Key Takeaway: The article discusses the in vitro evaluation of the microbicidal efficacy of BIASURGE® Advanced Surgical Solution. It emphasizes the importance of consulting healthcare professionals for medical advice and product usage. The content serves as informational and does not substitute for professional guidance or manufacturer instructions.
Price reaction · baseline $34.44 (2025-09-18T15:41:00.000Z) · hit during market hours · 2 other SMTI headline(s) in the window, move may be shared
day 0 close · peak
+0.6%

Market Sentiment Analysis

Full Press Release Details

• Last Updated on February 10, 2026
Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute for manufacturer instructions nor create new product claims. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Please refer to our Terms of Use .

Related Posts

• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• Last Updated on April 7, 2026
Prodromos Ververeli, MD & Asaf Yalif, MD & Rory Snepar, DO
• About Sanara
• Board of Directors
• Surgical Products
• Code of Conduct
• Stock Quote
• Press Releases
• SEC Filings
© 2026 All Rights Reserved. Sanara MedTech Inc.
Last updated: Sep 18, 2025